CD44 and malignant glioma: However, further analysis found that NCR3LG1 shows negative relationship with CD44 in glioma (Supplementary Figure 10), which may be partially explained by the low expression in malignant glioma and positive glioma survival biomarker of NCR3LG1 (Supplementary Figure 11).